Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | APD | LIN |
|---|---|---|
| Price | $285.84 | $470.08 |
| Change today | ▼ 0.40% | ▲ 0.08% |
| Market cap | $63.65B | $216.70B |
| Return, 3 months | +3.2% | -8.6% |
| Return, year to date | +18.0% | +11.3% |
| Return, 1 year | +7.8% | +0.5% |
| P/E (TTM) | -1,361.1 | 30.3 |
| P/B | 4.6 | 5.5 |
| P/E percentile vs own 5y | 2nd | 5th |
| Dividend yield | 2.52% | 1.32% |
| Revenue growth (YoY, latest qtr) | +4.6% | +9.3% |
| Net profit growth (YoY) | -296.7% | +9.2% |
| Gross margin | 32.1% | 48.3% |
| Operating margin | 24.8% | 27.1% |
| Net margin | -0.4% | 20.4% |
| Return on equity | -0.3% | 18.7% |
| Analyst target vs. price | +18.8% | +19.2% |
| Analyst buy share | 64% | 85% |
| RSI (14) | 44 | 48 |
| 30-day volatility | 19.7% | 15.7% |
| Max drawdown, 1 year | -21.1% | -19.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.